SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of TG Therapeutics, Inc. (TGTX)
NEW YORK, NY / ACCESSWIRE / January 11, 2017 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX). Such investors are advised to join this case by visiting the firm's site: http://www.bgandg.com/tgtx.
The investigation concerns whether TG Therapeutics and certain of its officers and/or directors have violated federal securities laws.
If you are aware of any facts relating to this investigation, or if you purchased shares of TG Therapeutics, you can assist this investigation by visiting the firm's site: http://www.bgandg.com/tgtx or by contacting Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. Those who inquire by e-mail are encouraged to include their mailing address, email, and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
